These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8099886)

  • 1. Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda.
    Garey JR; Franklin KF; Brown DA; Harrison LM; Metcalf KM; Kushner JP
    Gastroenterology; 1993 Jul; 105(1):165-9. PubMed ID: 8099886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles.
    Mendez M; Sorkin L; Rossetti MV; Astrin KH; del C Batlle AM; Parera VE; Aizencang G; Desnick RJ
    Am J Hum Genet; 1998 Nov; 63(5):1363-75. PubMed ID: 9792863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uroporphyrinogen decarboxylase gene mutations in Danish patients with porphyria cutanea tarda.
    Christiansen L; Bygum A; Jensen A; Brandrup F; Thomsen K; Horder M; Petersen NE
    Scand J Clin Lab Invest; 2000 Nov; 60(7):611-5. PubMed ID: 11202053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in familial porphyria cutanea tarda: two novel and two previously described for hepatoerythropoietic porphyria.
    Mendez M; Rossetti MV; De Siervi A; del Carmen Batlle AM; Parera V
    Hum Mutat; 2000 Sep; 16(3):269-70. PubMed ID: 10980536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mouse model of familial porphyria cutanea tarda.
    Phillips JD; Jackson LK; Bunting M; Franklin MR; Thomas KR; Levy JE; Andrews NC; Kushner JP
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):259-64. PubMed ID: 11134514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point mutation in the coding region of uroporphyrinogen decarboxylase associated with familial porphyria cutanea tarda.
    Garey JR; Hansen JL; Harrison LM; Kennedy JB; Kushner JP
    Blood; 1989 Mar; 73(4):892-5. PubMed ID: 2920211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seven novel point mutations in the uroporphyrinogen decarboxylase (UROD) gene in patients with familial porphyria cutanea tarda (f-PCT).
    Cappellini MD; Martinez di Montemuros F; Tavazzi D; Fargion S; Pizzuti A; Comino A; Cainelli T; Fiorelli G
    Hum Mutat; 2001 Apr; 17(4):350. PubMed ID: 11295834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional consequences of naturally occurring mutations in human uroporphyrinogen decarboxylase.
    Phillips JD; Parker TL; Schubert HL; Whitby FG; Hill CP; Kushner JP
    Blood; 2001 Dec; 98(12):3179-85. PubMed ID: 11719352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular basis of porphyria cutanea tarda in Chile: identification and functional characterization of mutations in the uroporphyrinogen decarboxylase gene.
    Poblete-Gutiérrez P; Mendez M; Wiederholt T; Merk HF; Fontanellas A; Wolff C; Frank J
    Exp Dermatol; 2004 Jun; 13(6):372-9. PubMed ID: 15186324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda.
    Phillips JD; Bergonia HA; Reilly CA; Franklin MR; Kushner JP
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5079-84. PubMed ID: 17360334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus].
    Wolff C; Stella AM; Armas R; Parraguez A; Silva H; Batlle AM
    Rev Med Chil; 1998 Mar; 126(3):245-50. PubMed ID: 9674292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and kinetic characterization of mutant human uroporphyrinogen decarboxylases.
    Warby CA; Phillips JD; Bergonia HA; Whitby FG; Hill CP; Kushner JP
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):40-5. PubMed ID: 19656450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
    Bygum A; Christiansen L; Petersen NE; Hørder M; Thomsen K; Brandrup F
    Acta Derm Venereol; 2003; 83(2):115-20. PubMed ID: 12735639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.
    Weiss Y; Chen B; Yasuda M; Nazarenko I; Anderson KE; Desnick RJ
    Mol Genet Metab; 2019 Nov; 128(3):363-366. PubMed ID: 30514647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uroporphyrinogen decarboxylase: complete human gene sequence and molecular study of three families with hepatoerythropoietic porphyria.
    Moran-Jimenez MJ; Ged C; Romana M; Enriquez De Salamanca R; Taïeb A; Topi G; D'Alessandro L; de Verneuil H
    Am J Hum Genet; 1996 Apr; 58(4):712-21. PubMed ID: 8644733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the UROD gene in 17 Argentinean patients with familial porphyria cutanea tarda: characterization of four novel mutations.
    Méndez M; Rossetti MV; Gómez-Abecia S; Morán-Jiménez MJ; Parera V; Batlle A; Enríquez de Salamanca R
    Mol Genet Metab; 2012 Apr; 105(4):629-33. PubMed ID: 22382040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uroporphyrinogen decarboxylase: a splice site mutation causes the deletion of exon 6 in multiple families with porphyria cutanea tarda.
    Garey JR; Harrison LM; Franklin KF; Metcalf KM; Radisky ES; Kushner JP
    J Clin Invest; 1990 Nov; 86(5):1416-22. PubMed ID: 2243121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of uroporphyrinogen decarboxylase (URO-D) in erythrocytes of Italian porphyria cutanea tarda patients.
    Tavazzi D; Martinez di Montemuros F; Fargion S; Fracanzani AL; Fiorelli G; Cappellini MD
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):27-32. PubMed ID: 11929044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular heterogeneity of familial porphyria cutanea tarda in Spain: characterization of 10 novel mutations in the UROD gene.
    Méndez M; Poblete-Gutiérrez P; García-Bravo M; Wiederholt T; Morán-Jiménez MJ; Merk HF; Garrido-Astray MC; Frank J; Fontanellas A; Enríquez de Salamanca R
    Br J Dermatol; 2007 Sep; 157(3):501-7. PubMed ID: 17627795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.